Showing 6,261 - 6,280 results of 7,685 for search 'initial detection', query time: 0.15s Refine Results
  1. 6261

    Autoimmune Hepatitis Triggered by Anti-TNF- Therapy by Satoshi Nakayama

    Published 2013-01-01
    “…A 52-year-old Japanese woman with psoriasis developed liver damage two months after initiation of anti-TNF-α therapy with adalimumab. Liver histological findings were compatible with AIH, and positive conversions of ANAs were detected. …”
    Get full text
    Article
  2. 6262

    Injury-Driven Structural and Molecular Modifications in Nociceptors by Mario García-Domínguez

    Published 2025-06-01
    “…Peripheral tissue injury initiates a multifaceted cascade of structural and molecular modifications within nociceptors, the primary sensory neurons tasked with detecting noxious stimuli. …”
    Get full text
    Article
  3. 6263
  4. 6264

    Tularemia in Bulgaria 2003-2004 by Radka Komitova, Rumiana Nenova, Plamen Padeshki, Ivan Ivanov, Vassil Popov, Petar Petrov

    Published 2010-09-01
    “…Francisella tularensis (F. tularensis) was detected by PCR, providing a definitive diagnosis in 82.3% of the cases. …”
    Get full text
    Article
  5. 6265

    Brain Infarction in Botulism (Clinical Case) by R. E. Kalinin, E. Kh. Barinov, D. V. Sundukov

    Published 2020-04-01
    “…In 6 out of 89 criminal «iatrogenic» cases initiated by investigative authorities in the Moscow region in 2016–2018 anesthesiological or intensive care in the ICU was the subject of investigation. …”
    Get full text
    Article
  6. 6266

    Discovering and modeling hidden periodicities in science data by Antonio Napolitano, William A. Gardner

    Published 2025-04-01
    “…The popularity stems from the fact that detecting and characterizing periodicities can provide a means for extracting information from science data—information that might not otherwise be accessible. …”
    Get full text
    Article
  7. 6267

    An ACTH-Producing Neuroendocrine Tumor: Clinical Course of Multidisciplinary Therapy Including Peptide Receptor Radionuclide Therapy – A Case Report by Tomonobu Koizumi, Ai Sato, Kohei Kitajima, Masanori Yamazaki, Sana Kanazawa, Tsuyoshi Notake, Yoshinori Sato, Shota Kobayashi, Mai Iwaya, Takako Umeda, Mitsuhisa Komatsu

    Published 2025-01-01
    “…ACTH levels increased after initiation of PRRT, and clinical manifestations, such as pigmentation, hypertension, and hyperglycemia, were remarkable. …”
    Get full text
    Article
  8. 6268

    Spontaneous Dramatic Regression of Clear Cell Renal Cell Carcinoma After Pazopanib-Induced Severe Systemic Inflammatory Syndrome: A Case Report and Literature Review by Chi Hyuk Oh, Hong Jun Kim

    Published 2025-04-01
    “…This case report presents a unique instance of spontaneous dramatic tumor regression in a 42-year-old Korean male diagnosed with clear cell RCC. The patient initially presented with right lower back pain, weight loss, and a loss of appetite. …”
    Get full text
    Article
  9. 6269

    Round Spermatid Injection Rescues Female Lethality of a Paternally Inherited Xist Deletion in Mouse. by Federica Federici, Aristea Magaraki, Evelyne Wassenaar, Catherina J H van Veen-Buurman, Christine van de Werken, Esther B Baart, Joop S E Laven, J Anton Grootegoed, Joost Gribnau, Willy M Baarends

    Published 2016-10-01
    “…In addition, no Xist expression was detected in male and female morulas that developed from oocytes fertilized with mature ΔXist sperm. …”
    Get full text
    Article
  10. 6270

    The N-formyl peptide receptors: much more than chemoattractant receptors. Relevance in health and disease by Filomena Napolitano, Nunzia Montuori, Nunzia Montuori

    Published 2025-03-01
    “…Pattern Recognition Receptors (PRRs) are a superfamily of receptors that detect molecular structures typical for pathogens and damaged cells and play a crucial role in the proper function of the innate immune system. …”
    Get full text
    Article
  11. 6271

    Study of some virulence genes from uropathogenic Klebsiella pneumoniae and Pseudomonas aeruginosa isolated in Wasit Province, Iraq by Rana H. Raheema, Sabaa Hilal Hadi, Zainab Adil Ghani Chabuck

    Published 2024-01-01
    “…Materials and Methods: Initially, 100 clinical urine samples were taken for this investigation from (October 1 to December 1, 2022), and the isolates were initially identified using culture, microscopic analysis, and biochemical assays. …”
    Get full text
    Article
  12. 6272

    Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives by Shiheng Jia, Xue Yu, Na Deng, Chen Zheng, Mingguang Ju, Fanglin Wang, Yixiao Zhang, Ziming Gao, Yanshu Li, Heng Zhou, Kai Li

    Published 2025-01-01
    “…Increased pseudouridylation is frequently associated with tumour initiation, progression, and poor prognosis, whereas its reduction is predominantly implicated in non‐tumour diseases. …”
    Get full text
    Article
  13. 6273
  14. 6274

    Cutibacterium Acnes induces Alzheimer’s disease-like pathology in brains of wistar rats through structural changes associated with microtubules by Morteza Aliashrafi, Mohammad Nasehi, Seyed Davar Siadat, Mohammad-Hossein Mohammadi-Mahdiabadi-Hasani, Hakimeh Zali, Zahra Niknam

    Published 2024-11-01
    “…Abstract Background Cutibacterium acnes ( C. acnes), a Gram-positive anaerobe and a dominant bacterium species in the sebaceous follicles of the face was detected in the brain of Alzheimer’s disease (AD) patients. …”
    Get full text
    Article
  15. 6275

    Abdominal B-Cell Lymphoma Mimicking Ovarian Cancer by Dennis Jung, Lina Judit Schiestl, Simin Schadmand-Fischer, Arno Schad, Annette Hasenburg, Roxana Schwab

    Published 2024-10-01
    “…In gynecological sonography ascites, an ovarian cyst and peritoneal carcinosis in the pouch of Douglas were detected, which were potentially indicative of ovarian cancer. …”
    Get full text
    Article
  16. 6276

    Long-term follow-up of combination therapy with pembrolizumab and anlotinib in thoracic SMARCA4-deficient undifferentiated tumor: a case report and molecular features by Ting Duan, Mingxin Xu, Haibo Zhang, Shengchang Wu, Haochu Wang, Zhenying Guo

    Published 2024-12-01
    “…After 46 cycles, the patient demonstrated no disease progression with a PR lasting 31 months and long progression-free survival(PFS) of 43 months. The lung tumor was initially detected in September 2020, and the patient remained alive at the latest follow-up in November 2024. …”
    Get full text
    Article
  17. 6277

    Case Report: Dramatic response to entritinib in a patient with gastrointestinal stromal tumor positive for NTRK3 fusion by Guomin Dong, Pengyu Han, Zhiyun Zhang, Qian Ge, Jian Jiang, Suoni Li, Jiequn Ma, Jie Bai, Hui Wei, Zheng Zhao

    Published 2025-08-01
    “…Continued oral imatinib adjuvant therapy was initiated. In 2024, disease progression was observed with residual KIT mutation (VAF 1.10%) and new-onset ETV6:NTRK3 fusion (VAF 35.29%) detected by circulating tumor DNA (ctDNA) analysis. …”
    Get full text
    Article
  18. 6278
  19. 6279

    Identification of diagnostic and prognostic genetic alterations in uveal melanoma using RNA sequencing by Rogier J. Nell, Mieke Versluis, Davy Cats, Hailiang Mei, Robert M. Verdijk, Wilma G. M. Kroes, Gregorius P. M. Luyten, Martine J. Jager, Pieter A. van der Velden

    Published 2025-03-01
    “…Here, we tested the detectability of all key mutations and chromosomal changes from RNA sequencing data in 80 primary uveal melanomas studied by The Cancer Genome Atlas (TCGA) initiative, and in five prospective cases. …”
    Get full text
    Article
  20. 6280

    Ponatinib as a Valid Alternative Strategy in Patients with Blast Crisis-Chronic Myeloid Leukemia Not Eligible for Allogeneic Stem Cells Transplantation and/or Conventional Chemothe... by Cristina Bucelli, Daniele Cattaneo, Valeria Ferla, Manuela Zappa, Caterina de Benedittis, Simona Soverini, Alessandra Iurlo

    Published 2017-01-01
    “…Here we report the case of a 61-year-old man diagnosed with B-cell lymphoid BC-CML, initially treated with imatinib 800 mg day and then with dasatinib 140 mg day because of intolerance. …”
    Get full text
    Article